Search results
adidas Superstar Sneakers Aren’t Going Anywhere — Here Are the Best Ones to Buy Now.
Footwear News via Yahoo News· 5 hours agoThe chunky style stays true to the Superstar’s DNA with the leather upper, EVA sock liner, and...
Gateway - Quartz
Quartz· 6 days ago23andMe is in a death spiral. Almost everyone who wants a DNA test already bought one, a nightmare data breach ruined the company’s reputation, and 23andMe’s stock ...
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 3 days agoPrime Medicine has an expected revenue and earnings growth rate of more than 100% and 19.2%,...
Ginkgo Bioworks has begun laying off employees this week - Boston Business Journal
The Business Journals· 6 days agoGinkgo Bioworks began making layoffs this week. Ginkgo Bioworks Holdings Inc. (NYSE: DNA) is...
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 5 days agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 1.8%
ETF DAILY NEWS· 6 days agoShares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) dropped 1.8% on Monday . The stock traded as low as $61.36 and last traded at $62.40. Approximately 273,954 ...
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Zacks via Yahoo Finance· 6 days agoCharles River (CRL) and Captain T Cell announced an agreement on plasmid DNA and retrovirus vector...
Cathie Wood sells $13 million of a struggling tech stock
TheStreet.com· 2 days agoThe Nasdaq Composite Index has jumped 18% year to date. Is Cathie Wood, head of Ark Investment...
Sienna Wildgust Blindsides Her KB Titan Racing NHRA Team, Jumps to Elite Motorsports
AutoWeek· 23 hours agoBarely more than two and a half months ago, NHRA Pro Stock points leader and 105-time winner Greg...
Virtu Financial LLC Invests $526,000 in Twist Bioscience Co. (NASDAQ:TWST)
ETF DAILY NEWS· 7 days ago(NASDAQ:TWST – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 14,273 shares of the company’s stock